Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
ACTR2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
CNOT6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GNG10 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LIN7C - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
STYX - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SFR1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GPR160 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ABHD2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SSR1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LAPTM4B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GRSF1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PTBP3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SCOC - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
BAG5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
YME1L1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GFM1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SERP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
JKAMP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
APPBP2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SRD5A1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on